In conclusion, our results suggest that excitatory neuron-specific reduction of CYFIP2 is insufficient to induce AD-like pathologies in the hippocampal CA1 region, warranting further investigation into the neuronal circuit-dependent mechanisms of AD pathology induced by CYFIP2 reduction. The gene discussed is CYFIP2; the disease is Alzheimer disease.